Properties and Composition of Normal Cerebrospinal Fluid

Cerebrospinal Fluid in Clinical Practice

Volumn , Issue , 2009, Pages 69-89

  Irani, David N ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882481898     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141602908-3.50013-3     Document Type: Chapter

References (179)

1. Fishman RA Cerebrospinal Fluid in Diseases of the Nervous System 1992, W.B. Saunders, Philadelphia. 2nd ed.
2. Simon RP, Abele JS Spinal-fluid pleocytosis estimated by the Tyndall effect. Ann Intern Med 1978, 89:75-76.
3. Barrows LJ, Hunter FT, Banker BQ The nature and clinical significance of pigments in the cerebrospinal fluid. Brain 1955, 78:59-80.
4. Oehmichen M Cerebrospinal Fluid Cytology: an Introduction and Atlas 1976, W.B. Saunders, Philadelphia.
5. Oehmichen M, Gruninger H Cytokinetic studies on the origin of cells in the cerebrospinal fluid. J Neurol Sci 1974, 22:165-176.
6. Ransohoff RM, Kivisakk P, Kidd G Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 2003, 3:569-581.
7. Carrithers MD, Visintin I, Kang SJ, Janeway CA Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment. Brain 2000, 123:1092-1101.
8. Cserr HF, Knopf PM Cervical lymphatics, the blood-brain barrier, and the immunoreactivity of the brain: a new view. Immunol Today 1992, 13:507-512.
9. Veerman A, Huismans L, Van Zantwijk I Storage of cerebrospinal fluid samples at room temperature. Acta Cytol 1985, 29:189-190.
10. Aune MW, Becker JL, Brugnara C, et al. Automated flow cytometric analysis of blood cells in cerebrospinal fluid: analytic performance. Am J Clin Pathol 2004, 121:690-700.
11. Svenningsson A, Andersen O, Edsbagge M, Stemme S Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid. J Neuroimmunol 1995, 63:39-46.
12. Svenningsson A, Hansson GK, Andersen O, Andersson R, Patarroyo M Stemme S. Adhesion molecule expression in cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls. Ann Neurol 1993, 34:155-161.
13. Kivisakk P, Trebst C, Liu Z, et al. T cells in cerebrospinal fluid express a similar repertoire of inflammatory receptors in the absence or presence of CNS inflammation: implications for CNS trafficking. Clin Exp Immunol 2002, 129:510-518.
14. Kivisakk P, Mahad DJ, Callahan MK, et al. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci USA 2003, 100:8389-8394.
15. Simon RP, Koerper MA PMNs in normal spinal fluid examined by the cytocentrifuge technique. Ann Neurol 1980, 7:380-381.
16. Wilkins RH, Odom GL Ependymal-choroidal cells in cerebrospinal fluid. Increased incidence in hydrocephalic infants. J Neurosurg 1974, 41:555-560.
17. Chen KT, Moseley D Cartilage cells in cerebrospinal fluid. Arch Pathol Lab Med 1990, 114:212.
18. Craver RD, Carson TH Hematopoietic elements in cerebrospinal fluid in children. Am J Clin Pathol 1991, 95:532-535.
19. Thompson EJ Proteins of the Cerebrospinal Fluid. Analysis and Interpretation in the Diagnosis and Treatment of Neurological Disease 2005, Elsevier Academic Press, Amsterdam. second edition.
20. Felgenhauer K Protein size and cerebrospinal fluid composition. Klin Wochenschr 1974, 36:66-69.
21. Griffin DE, Giffels J Study of protein characteristics that influence entry into the cerebrospinal fluid of normal mice and mice with encephalitis. J Clin Invest 1982, 70:289-295.
22. Cutler RW P, Watters GV, Hammerstad JP The origin and turnover of cerebrospinal fluid albumin and gamma globulin in man. J Neurol Sci 1970, 10:259-268.
23. Widell S On the cerebrospinal fluid in normal children and patients with acute bacterial meningoencephalitis. Acta Paediatr 1958, (Suppl 115):1-102.
24. Dencker SJ Variation of total cerebrospinal fluid proteins and cells with sex and age. World Neurol 1962, 3:778-780.
25. Tourtellotte WW, Haerer AF, Heller GL Post-Lumbar Puncture Headaches 1964, Charles C. Thomas, Springfield, IL.
26. Laterre EC Les Protéines du Liquide Céphalorachidien a L'état Normal et Pathologique 1965, 148-161. Editions Arscia, Bruxelles, Paris: Librarie Maloine;.
27. Cosgrove JB, Agius P Studies in multiple sclerosis. II. Comparison of the beta-gamma globulin ratio, gamma globulin elevation, and first zone colloidal gold curve in the cerebrospinal fluid. Neurology 1966, 16:197-204.
28. Gillard O Lumbar cerebrospinal fluid total protein in healthy subjects. Acta Neurol Scand 1967, 43:526-529.
29. Merritt HH, Fremont-Smith F The Cerebrospinal Fluid 1938, W.B. Saunders, Philadelphia.
30. Fishman RA, Ransohoff J, Osserman EF Factors influencing the concentration gradient of protein in cerebrospinal fluid. J Clin Invest 1958, 37:1419-1428.
31. Weisner B, Bernhardt W Protein fractions of lumbar, cisternal, and ventricular cerebrospinal fluid. J Neurol Sci 1978, 37:205-214.
32. McGale EH F, Pye IF, Stonier C, Hutchinson EC, Aber GM Studies of the interrelationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals. J Neurochem 1977, 29:291-297.
33. Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel FA Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationships in healthy subjects. J Neurochem 1984, 42:833-837.
34. Heiblim DI, Evans HE, Glass L, Agbayani MM Child neurology: amino acid concentrations in cerebrospinal fluid. Arch Neurol 1978, 35:765-768.
35. Werner MA A combined procedure for protein estimation and electrophoresis of cerebrospinal fluid. J Lab Clin Med 1969, 74:166-173.
36. Schultze HE, Heremans JF Molecular Biology of the Human Proteins, Volume I 1966, 732-761. Elsevier, Amsterdam.
37. Fishman RA, Ransohoff J, Osserman EF Factors influencing the concentration gradient of protein in cerebrospinal fluid. J Clin Invest 1958, 37:1419-1424.
38. Grubb A Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 1992, (38 Suppl):S20-S27.
39. Yamada T, Mukaiyama I, Miyake N, Igari J Measurement of cystatin C in cerebrospinal fluid. Rinsho Byori 2002, 50:613-617.
40. Nerenberg ST, Prasad R, Rothman ME Cerebrospinal fluid IgG, IgA, IgM, IgD, and IgE levels in central nervous system disorders. Neurology 1978, 28:988-990.
41. Tibbling G, Link H, Ohman S Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 1977, 37:385-390.
42. Delpech B, Lichtblau F Etude quantitative des immunoglobulines G et de l'albumine du liquide céphalo-rachidien. Clin Chim Acta 1972, 37:15-23.
43. Olsson JE, Pettersson B A comparison between agar gel electrophoresis and CSF serum quotients of IgG and albumin in neurological diseases. Acta Neurol Scand 1976, 53:308-322.
44. Sharief MK, Hentges R, Thomas E Significance of CSF immunoglobulins in monitoring neurologic disease activity in Behçet's disease. Neurology 1991, 41:1398-1401.
45. Kenney K, Brechtel C, Takahashi H, Kurohara K, Anderson P, Gibbs CJ An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients. Ann Neurol 2000, 48:395-398.
46. Rosengren LE, Karlsson JE, Karlsson JO, Persson LI, Wikkelso C Patients with amytrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem 1996, 67:2013-2018.
47. Petzold A, Keir G, Green AJ, Giovannoni G, Thompson EJ A specific ELISA for measuring neurofilament heavy chain phosphoforms. J Immunol Methods 2003, 278:179-190.
48. Casmiro M, Maitan S, De Pasquale F, Cova V, Scarpa E, Vignatelli L Cerebrospinal fluid and serum neuron-specific enolase concentrations in a normal population. Eur J Neurol 2005, 12:369-374. NSE Study Group.
49. Petzold A, Keir G, Green AJ, Giavannoni G, Thompson EJ An ELISA for glial fibrillary acidic protein. J Immunol Methods 2004, 287:169-177.
50. Green AJ, Keir G, Thompson EJ A specific and sensitive ELISA for measuring S-100B in cerebrospinal fluid. J Immunol Methods 1997, 205:35-41.
51. Beems T, Simons KS, Van Geel WJ, De Reus HP, Vos PE, Verbeek MM Serum- and CSF-concentrations of brain specific proteins in hydrocephalus. Acta Neurochir (Wien) 2003, 145:37-43.
52. Bilic E, Bilic E, Rudan I, et al. Comparison of the growth hormone, IGF-1, and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls. Eur J Neurol 2006, 13:1340-1345.
53. Peskind ER, Wilkinson CW, Petrie EC, Schellenberg GD, Raskind MA Increased CSF cortisol in AD is a function of APOE genotype. Neurology 2001, 56:1094-1098.
54. Zheng W, Lu Y-M, Lu G-Y, Zha Q, Cheung O, Blaner WS Transthyretin, thyroxine, and retinol-binding protein in human cerebrospinal fluid: effect of lead exposure. Toxicol Sci 2001, 61:107-114.
55. Rousseau A, Petren S, Plannthin J, Eklundh T, Nordin C Serum and cerebrospinal fluid concentrations of melatonin: a pilot study in healthy male volunteers. J Neural Transm 1999, 106:883-888.
56. Kaneko T, Shirakami G, Nakao K, et al. C-type natriuretic peptide (CNP) is the major natriuretic peptide in human cerebrospinal fluid. Brain Res 1993, 612:104-109.
57. Mathe AA, Agren H, Wallin A, Blennow K Calcitonin gene-related peptide and calcitonin in the CSF of patients with dementia and depression: possible disease markers. Prog Neuro-Psychopharm Biol Psychiatry 2002, 26:41-48.
58. Taiwo OB, Russell IJ, Mignot E, et al. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome. Sleep Med 2007, 8:260-265.
59. Altemus M, Jacobson KR, Debellis M, et al. Normal CSF oyxtocin and NPY levels in OCD. Biol Psychiatry 1999, 45:931-933.
60. Bjorkqvist M, Leavitt BR, Neilsen JE, et al. Cocaine- and amphetamine-regulated transcript is increased in Huntington's disease. Movement Disorders 2007, 22:1952-1954.
61. Banik NL, Hogan EL Cerebrospinal fluid enzymes in neurological disease. Neurobiology of Cerebrospinal Fluid 1983, 2:205-231. Plenum Press, New York. J.H. Wood (Ed.).
62. Stover JF, Lowitzsch K, Kempski OS Cerebrospinal fluid hypoxanthine, xanthine and uric acid levels may reflect glutamate-mediated excitotoxicity in different neurological diseases. Neurosci Lett 1997, 238:25-28.
63. Nussinovitch M, Prais D, Volovitz B, Amir J, Harel D, Nussinovich A Reference values for lactate dehydrogenase activity and isoenzyme distribution in cerebrospinal fluid in neonates with fever but no evidence of cerebral disease. Am J Perinatol 2002, 19:109-114.
64. Dalens B, Viallard JL, Raynaud EJ, Dastugue B Enzyme studies and neonatal brain damage. Acta Paediatr Scand 1981, 70:743-749.
65. Vazquez MD, Sanchez-Rodriguez F, Osuna E, et al. Creatine kinase BB and neuron-specific enolase in cerebrospinal fluid in the diagnosis of brain insult. Am J Forensic Med Pathol 1995, 16:210-214.
66. Coplin WM, Longstreth WT, Lam AM, et al. Cerebrospinal fluid creatine kinase-BB isoenzyme activity and outcome after subarachnoid hemorrhage. Arch Neurol 1999, 56:1348-1352.
67. Lescuyer P, Gandini A, Burkhard PR, Hochstrasser DF, Sanchez J-C Prostaglandin D2 synthetase and its post-translational modifications in neurological disorders. Electrophoresis 2005, 26:4563-4570.
68. Kanekiyo T, Ban T, Aritake K, et al. Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid. Proc Natl Acad Sci USA 2007, 104:6412-6417.
69. Rapaport MH, McAllister CG, Pickar D, Tamarkin L, Kirch DG, Paul SM CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers. Schizophr Res 1997, 25:123-129.
70. Tarkowski E, Andreasen N, Tarkowski A, Blennow K Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003, 74:1200-1205.
71. Stoeck K, Bodemer M, Ciesielczyk B, et al. Interleukin 4 and interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Arch Neurol 2005, 62:1591-1594.
72. Steensberg A, Dalsgaard MK, Secher NH, Pedersen BK Cerebrospinal fluid IL-6, HSP72, and TNF-α in exercising humans. Brain Behav Immun 2006, 20:585-589.
73. Brisby H, Olmarker K, Larsson K, Nutu M, Rydevik B Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica. Eur Spine J 2002, 11:62-66.
74. Natelson BH, Weaver SA, Tseng C-L, Ottenweller JE Spinal fluid abnormalities in patients with chronic fatigue syndrome. Clin Diagn Lab Immunol 2005, 12:52-55.
75. Li X, Miyajima M, Jiang C, Arai H Expression of TGF-βs and TGF-β type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus. Neurosci Lett 2007, 413:141-144.
76. Pashenkov M, Soderstrom M, Huang YM, Link H Cerebrospinal fluid affects phenotype and functions of myeloid dendritic cells. Clin Exp Immunol 2002, 128:379-387.
77. Taylor AW, Streilein JW Inhibition of antigen-stimulated effector T cells by human cerebrospinal fluid. Neuroimmunomodulation 1996, 3:112-118.
78. Franciotta D, Zardini E, Ravaglia S, et al. Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis. J Neurol Sci 2006, 247:202-207.
79. Rancan M, Bye N, Otto VI, et al. The chemokine fractalkine in patients with severe traumatic brain injury and a mouse model of closed head injury. J Cereb Blood Flow Metab 2004, 24:1110-1118.
80. Rupprecht TA, Koedel U, Muhlberger B, Wilske B, Fontana A, Pfister HW CXCL11 is involved in leukocyte recruitment to the central nervous system in neuroborreliosis. J Neurol 2005, 252:820-823.
81. Yushchenko M, Weber F, Mader M, et al. Matrix metalloproteinase-9 (MMP-9. in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count. J Neuroimmunol 2000, 110:244-251.
82. Rodriguez M, Wynn DR, Kimlinger TK, Katzmann JA Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls. Neurology 1990, 40:855-857.
83. Jongen PJ H, Doesburg WH, Ibrahim-Stappers LJ M, Lemmens WAJG, Hommes OR, Lamers KJ B Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system. Acta Neurol Scand 2000, 101:116-121.
84. Loeffler DA, Brickman CM, Juneau PL, Perry MF, Pomara PN, Lewitt PA Cerebrospinal fluid C3a increases with age, but does not increase further in Alzheimer's disease. Neurobiol Aging 1997, 18:555-557.
85. Henningsson AJ, Ernerudh J, Sandholm K, et al. Complement activation in Lyme neuroborreliosis - increased levels of C1q and C3a in cerebrospinal fluid indicate complement activation in the CNS. J Neuroimmunol 2007, 183:200-207.
86. Shimetani N, Shimetani K, Mori M Levels of three inflammation markers, C-reactive protein, serum amyloid A protein and procalcitonin, in the serum and cerebrospinal fluid of patients with meningitis. Scand J Clin Lab Invest 2001, 61:657. 574.
87. Rapoport SI, Schapiro MB, May C Reduced brain delivery of homovanillic acid to cerebrospinal fluid during human aging. Arch Neurol 2004, 61:1721-1724.
88. Lee J, Huang BX, Yuan Z, Kim H-Y Simultaneous determination of salsolinol enantiomers and dopamine in human plasma and cerebrospinal fluid by chemical derivatization coupled to chiral liquid chromatography/electrospray ionization-tandem mass spectrometry. Anal Chem 2007, 79:9166-9173.
89. Kalita J, Kumar S, Vijaykumar K, Palit G, Misra UK A study of CSF catecholamine and its metabolites in acute and convalescent period of encephalitis. J Neurol Sci 2007, 252:62-66.
90. Eklundh T, Eriksson M, Sjoberg S, Nordin C Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects. J Psychiat Res 1996, 30:201-208.
91. Frölich L, Dirr A, Götz ME, et al. Acetylcholine in human CSF: methodological considerations and levels in dementia of Alzheimer type. J Neural Transm 1998, 105:961-973.
92. Vieira DS S, Naffah-Mazacoratti MG, Zukerman E, et al. Cerebrospinal fluid GABA levels in chronic migraine with and without depression. Brain Res 2006, 1090:197-201.
93. Molina JA, Gomez P, Vargas C, et al. Neurotransmitter amino acid in cerebrospinal fluid of patients with dementia with Lewy bodies. J Neural Transm 2005, 112:557-563.
94. Vieira DS S, Naffah-Mazacoratti MG, Zukerman E, Senne Soares CA, Cavalheiro EA, Peres MF P Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine. Headache 2007, 47:842-847.
95. Wray HL, Winegrad AI Free fructose in human cerebrospinal fluid. Diabetologia 1966, 2:82-85.
96. Kusmierz J, DeGeorge JJ, Sweeney D, May C, Rapoport SI Quantitative analysis of polyols in human cerebrospinal fluid. J Chromatogr 1989, 497:39-48.
97. Shetty HU, Holloway HW, Rapoport SI Capillary gas chromatography combined with ion trap detection for quantitative profiling of polyols in cerebrospinal fluid and plasma. Anal Biochem 1995, 224:279-285.
98. Huck JH J, Verhoeven NM, Struys EA, Salomons GS, Jakobs C, van der Knaap M Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy. Am J Hum Genet 2004, 74:745-751.
99. Tourtellotte WW, Haerer AF Lipids in cerebrospinal fluid. XII. In multiple sclerosis and retrobulbar optic neuritis. Arch Neurol 1969, 20:605-615.
100. Tichy J, Alling C, Dencker SJ, Svennerholm L Fatty acid profiles of cerebrospinal fluid lipids in normals and chronic alcoholics. Scand J Clin Lab Invest 1970, 25:191-197.
101. Illingworth DR, Glover J The composition of lipids in cerebrospinal fluid of children and adults. J Neurochem 1971, 18:769-776.
102. Trbojevic-Cepe M, Kracun I Determination of gangliosides in human cerebrospinal fluid by high-performance liquid chromatography and direct densitometry. J Clin Chem Clin Biochem 1990, 28:863-872.
103. Trbojevic-Cepe M, Kracun I, Jusic A, Pavlicek I Gangliosides of human cerebrospinal fluid in various neurologic diseases. J Neurol Sci 1991, 105:192-199.
104. Han X, Fagan AM, Cheng H, Morris JC, Xiong C, Holtzman DM Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia. Ann Neurol 2003, 54:115-119.
105. Han X, Cheng H, Fryer JD, Fagan AM, Holtzman DM Novel role for apolipoprotein E in the central nervous system. Modulation of sulfatide content. J Biol Chem 2003, 278:8043-8051.
106. 2 levels in patients with probable AD. Neurology 1999, 53:1495-1498.
107. Vilanova JM, Figueras-Aloy J, Rosello J, Gomez G, Gelpi E, Jimenez R Arachadonic acid metabolites in CSF in hypoxic-ischemic encephalopathy of newborn infants. Acta Paediatr 1998, 87:588-592.
108. Nishino S, Mignot E, Benson KL, Zarcone VP Cerebrospinal fluid prostaglandins and corticotropin releasing factor in schizophrenics and controls. Psych Res 1998, 78:141-150.
109. Rebeck GW, Alonzo NC, Berezovska O, et al. Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes. Exp Neurol 1998, 149:175-182.
110. Koch S, Donarski N, Goetze K, et al. Characterization of four lipoprotein classes in human cerebrospinal fluid. J Lipid Res 2001, 42:1143-1151.
111. Hesse C, Larsson H, Fredman P, et al. Measurement of apolipoprotein E (apoE) in cerebrospinal fluid. Neurochem Res 2000, 25:511-517.
112. Kay A, Petzold A, Kerr M, Keir G, Thompson E, Nicoll J Temporal alterations in cerebrospinal fluid amyloid β-protein and apolipoprotein E after subarachnoid hemorrhage. Stroke 2003, 34:e240-e243.
113. Kay A, Petzold A, Kerr M, Keir G, Thompson E, Nicoll J Decreased cerebrospinal fluid apolipoprotein E after subarachnoid hemorrhage. Stroke 2003, 34:637-642.
114. Bradbury MW B, Kleeman CR Stability of the potassium content of cerebrospinal fluid and brain. Am J Physiol 1967, 213:519-528.
115. Bourke RS, Nelson KM Further studies on the K+-dependent swelling of the primate cerebral cortex in vivo: the enzymatic basis of the K+-dependent transport of chloride. J Neurochem 1972, 19:663-685.
116. Sambrook MA, Hutchison EC, Aber GM Metabolic studies after subarachnoid hemorrhage and strikes. II. Serial changes in cerebrospinal fluid and plasma electrolytes and osmolality. Brain 1973, 96:191-202.
117. Paulson GW, Stickney D Cerebrospinal fluid after death. Confin Neurol 1971, 33:149-162.
118. Katzman R, Pappius HM Brain Electrolytes and Fluid Metabolism 1973, Williams and Wilkins, Baltimore.
119. Tai CY, Smith QR, Rapoport SI Calcium influx into brain and cerebrospinal fluid are linearly related to plasma ionized calcium concentration. Brain Res 1986, 385:227-236.
120. Fishman RA Neurological manifestations of magnesium metabolism. Arch Neurol 1965, 12:562-569.
121. Conner JR, Menzies SL Cellular management of iron in the brain. J Neurol Sci 1995, (134 Suppl):33-44.
122. LeVine SM, Lynch SG, Ou C-N, Wulser MJ, Tam E, Boo N Ferratin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients. Brain Res 1999, 821:511-515.
123. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP Abnormalities in CSF concentrations of ferratin and transferrin in restless leg syndrome. Neurology 2000, 54:1698-1700.
124. Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J CSF iron, ferratin and transferrin levels in restless legs syndrome. J Sleep Res 2005, 14:43-47.
125. Stuerenburg HJ, Oechsner M, Schroeder S, Kunze K Determinants of copper concentration in cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1999, 67:252-253.
126. Melo TM, Larsen C, White LR, et al. Manganese, copper and zinc in cerebrospinal fluid from patients with multiple sclerosis. Biol Trace Elem Res 2003, 93:1-8.
127. Forte G, Bocca B, Senofonte O, et al. Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson's disease. J Neural Transm 2004, 111:1031-1040.
128. Paradowski M, Lobos M, Kuydowicz J, Krakowiak M, Kubasiewicz-Ujma B Acute phase proteins in serum and cerebrospinal fluid in the course of bacterial meningitis. Clin Biochem 1995, 28:459-466.
129. Stuerenburg HJ CSF copper concentrations, blood-brain barrier function, and ceruloplasmin synthesis during the treatment of Wilson's disease. J Neural Transm 2000, 107:321-329.
130. Tabassi A, Salmasi AH, Jalali M Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. Neurology 2005, 64:1893-1896.
131. Spector R, Johanson CE Vitamin transport and homeostasis in mammalian brain: focus on Vitamins B and E. J Neurochem 2007, 103:425-438.
132. Spector R, Johanson C Micronutrient and urate transport in choroid plexus and kidney: implications for drug therapy. Pharm Res 2006, 23:2515-2524.
133. Spector R Micronutrient homeostasis in mammalian brain and cerebrospinal fluid. J Neurochem 1989, 53:1667-1674.
134. Nijst TQ, Mevers RA, Schoonderwaldt HC, Hommes OR, de Haan AF Vitamin B12 and folate concentrations in serum and cerebrospinal fluid of neurological patients with special reference to multiple sclerosis and dementia. J Neurol Neurosurg Psychiatry 1990, 53:951-954.
135. Balabanova S, Richter HP, Antoniadis G, et al. 25-Hydroxyvitamin D, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human cerebrospinal fluid. Klin Wochenschr 1984, 62:1086-1090.
136. Vatassery GT, Nelson MJ, Maletta GJ, Kuskowski MA Vitamin E (tocopherols) in human cerebrospinal fluid. Am J Clin Nutr 1991, 53:95-99.
137. Vatassery GT, Fahn S, Kuskowski MA Alpha tocopherol in CSF of subjects taking high-dose vitamin E in the DATATOP study. Neurology 1998, 50:1900-1902.
138. Muting D, Heinze J, Reikowski J, Betzien G, Schwarz M, Schmidt FH Enzymatic ammonia determinations in the blood and cerebrospinal fluid of healthy persons. Clin Chem Acta 1968, 19:391-395.
139. Huizenga JR, Teelken AW, Tangerman A, de Jager AE, Gips CH, Jansen PL Determination of ammonia in cerebrospinal fluid using the indophenol direct method. Mol Chem Neuropathol 1998, 34:169-177.
140. Nybo L, Dalsgaard MK, Steensberg A, Moller K, Secher NH Cerebral ammonia uptake and accumulation during prolonged exercise in humans. J Physiol 2005, 563:285-290.
141. Bradbury MW B, Stubbs J, Hughes IE, Parker P The distribution of potassium, sodium, chloride and urea between lumbar cerebrospinal fluid and blood serum in human subjects. Clin Sci 1963, 25:97-105.
142. Swahn CG, Sedvall G CSF creatinine in schizophrenia. Biol Psychiatry 1988, 23:586-594.
143. De Deyn PP, Marescau B, Cuykens JJ, Van Gorp L, Lowenthal A, De Potter WP Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiency. Clin Chim Acta 1987, 167:81-88.
144. Gerrits GP J, Haagen AA M, De Abreu RA, et al. Reference values for nucleosides and nucleobases in cerebrospinal fluid of children. Clin Chem 1988, 34:1439-1442.
145. Rodriguez-Nunez A, Cid E, Rodriguez-Garcia J, Camina F, Rodriguez-Segade S, Castro-Gago M Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis. Brain Dev 2003, 25:102-106.
146. Stover JF, Lowitzsch K, Kempski OS Cerebrospinal fluid hypoxanthine, xanthine and uric acid levels may reflect glutamate-mediated excitotoxicity in different neurological diseases. Neurosci Lett 1997, 238:25-28.
147. Fleischer AS, Rudman DR, Fresh CB, Tindall GT Concentration of 3',5' cyclic adenosine monophosphate in ventricular CSF of patients following severe head trauma. J Neurosurg 1977, 47:517-524.
148. Maida E, Kristoferitsch W Cyclic adenosine 3',5' monophosphate in cerebrospinal fluid of multiple sclerosis patients. J Neurol 1981, 225:145-151.
149. Cramer H, Schindler E Cyclic nucleotides in cerebrospinal fluid of patients with intracranial and spinal tumors. Acta Neurol Scand 1982, 65:174-181.
150. Papageorgiou C, Gyftaki H, Mavrikakis M, Kesse-Elias M, Alevizou-Terzaki V, Kondou I Cerebrospinal fluid cyclic adenosine 3',5'-monophosphate in cases of severe cerebral ischemia and meningitis. Eur Neurol 1983, 22:12-16.
151. Lerche A, Svenson M, Wiik A Cerebrospinal fluid levels of cyclic nucleotides in meningitis and idiopathic polyneuritis. Acta Neurol Scand 1984, 69:168-175.
152. Buttner T, Hornig CR, Busse O, Dorndorf W CSF cyclic AMP and CSF adenylate kinase in cerebral ischaemic infarction. J Neurol 1986, 233:297-303.
153. Martinez M, Fernandez E, Frank A, Guaza C, de la Fuente M, Hernanz A Increased cerebrospinal fluid cAMP levels in Alzheimer's disease. Brain Res 1999, 846:265-267.
154. Tsang D, Lai S, Sourkes TL, Ford RM, Aronoff A Studies on cyclic AMP in different compartments of cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1976, 39:1186-1190.
155. Volicer L, Beal MF, Direnfeld LK, Marquis JK, Albert ML CSF cyclic nucleotides and somatostatin in Parkinson's disease. Neurology 1986, 36:89-92.
156. Ikeda M, Sato I, Matsunaga T, Takahashi M, Yuasa T, Murota S Cyclic guanosine monophosphate (cGMP), nitrite and nitrate in the cerebrospinal fluid in meningitis, multiple sclerosis and Guillain-Barré syndrome. Intern Med 1995, 34:734-737.
157. Navarro JA, Jimenez-Jimenez FJ, Molina JA, et al. Cerebrospinal fluid cyclic guanosine 3'5' monophosphate levels in Parkinson's disease. J Neurol Sci 1998, 155:92-94.
158. Ilecka J Decreased cerebrospinal fluid cGMP levels in patients with amotrophic lateral sclerosis. J Neural Transm 2004, 111:167-172.
159. Eells JT, Spector R Purine and pyrimidine base and nucleoside concentrations in human cerebrospinal fluid and plasma. Neurochem Res 1983, 8:1451-1457.
160. Macdonald RL, Weir BK, Marton LS, et al. Role of adenosine 5'-triphosphate in vasospasm after subarachnoid hemorrhage: human investigations. Neurosurgery 2001, 48:854-862.
161. Al-Khalidi HA S, Chaglassian TH The species distribution of xanthine oxidase. Biochem J 1965, 97:316-320.
162. Naschberger E, Lubeseder-Martellato C, Meyer N, et al. Human guanylate binding protein-1 is a secreted GTPase present in increased concentrations in the cerebrospinal fluid of patients with bacterial meningitis. Am J Pathol 2006, 169:1088-1099.
163. Posner JB, Plum F Independence of blood and cerebrospinal fluid lactate. Arch Neurol 1967, 16:492-496.
164. Halestrap AP, Price NT The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 1999, 343:281-299.
165. Zupping R, Kaasick AE, Ravdam E Cerebrospinal fluid metabolic acidosis and brain oxygen supply. Studies in patients with brain infarction. Arch Neurol 1971, 23:33-38.
166. Siesjo BK Brain Energy Metabolism 1978, 607. John Wiley & Sons, New York.
167. Parnetti L, Reboldi G, Gallai V Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia. Neurology 2000, 54:735-737.
168. Benoist J-F, Alberti C, Leclercq S, et al. Cerebrospinal fluid lactate and pyruvate concentrations and their ratio in children: age-related reference intervals. Clin Chem 2003, 49:487-494.
169. Blau N, Bonafe L, Krageloh-Mann I, et al. Cerebrospinal fluid pterins and folates in Aicardi-Goutieres syndrome. Neurology 2003, 61:642-647.
170. Leeming RJ, Blair JA, Melikian V, O'Gorman DJ Biopterin derivatives in human body fluids and tissues. J Clin Path 1976, 29:444-451.
171. Ramaekers VT, Rothenberg SP, Sequeira JM, Opladen T, Blau N, Quadros EV, Selhub J Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med 2005, 352:1985-1991.
172. Ormazabal A, Garcia-Cazorla A, Perez-Duenas B, et al. Determination of 5-methyltetrahydrofolate in cerebrospinal fluid of pediatric patients: reference values for a pediatric population. Clin Chim Acta 2006, 371:159-162.
173. 12 are related in blood and cerebrospinal fluid. Clin Chem 2007, 53:326-333.
174. Plum F, Price RW Acid-base balance of cisternal and lumbar cerebrospinal fluid. N Engl J Med 1973, 289:1346-1350.
175. Mitchell RA, Carman CT, Severinghaus JW, Richardson BW, Singer MM, Shnider S Stability of cerebrospinal fluid pH in chronic acid-base disturbances in blood. J Appl Physiol 1965, 20:443-452.
176. Mitchell RA, Herbert DA, Carman CT Acid-base constants and temperature coefficients for cerebrospinal fluid. J Appl Physiol 1965, 20:27-30.
177. Sambrook MA, Hutchinson EC, Aber GM Metabolic studies in subarachnoid hemorrhage and strokes. I. Serial changes in acid-base values in blood and cerebrospinal fluid. Brain 1973, 96:171-190.
178. Hermansen MC, Ellison PH Cerebrospinal fluid acid-base balance in newborns. Ann Neurol 1982, 11:344-346.
179. Siesjo BK The regulation of cerebrospinal fluid pH. Kidney Int 1972, 1:360-374.